Retrospective cohort study on the safety and efficacy of bevacizumab for metastatic colorectal cancer patients: The HGCSG0801 study—Efficacy of KRAS mutational status. Background: Capecitabine plus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback